Thomas Tüting
Thomas Tüting
Department of Dermatology, University Hospital Magdeburg, Germany
Verified email at med.ovgu.de
TitleCited byYear
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma‐specific T‐cell responses in humans following intranodal injection
H Jonuleit, A Giesecke‐Tuettenberg, T Tüting, B Thurner‐Schuler, ...
International journal of cancer 93 (2), 243-251, 2001
4492001
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ...
Nature medicine 20 (11), 1301, 2014
4382014
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ...
Nature 507 (7490), 109, 2014
3662014
5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
H Poeck, R Besch, C Maihoefer, M Renn, D Tormo, SS Morskaya, ...
Nature medicine 14 (11), 1256, 2008
3482008
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ...
Nature 490 (7420), 412, 2012
3372012
Attenuation of allergic contact dermatitis through the endocannabinoid system
M Karsak, E Gaffal, R Date, L Wang-Eckhardt, J Rehnelt, S Petrosino, ...
science 316 (5830), 1494-1497, 2007
3042007
Depletion of CD25+ CD4+ T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon α-induced, CD8+ T-cell-dependent immune …
J Steitz, J Brück, J Lenz, J Knop, T Tüting
Cancer research 61 (24), 8643-8646, 2001
2622001
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease
P Koch, P Breuer, M Peitz, J Jungverdorben, J Kesavan, D Poppe, J Doerr, ...
Nature 480 (7378), 543, 2011
2612011
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by …
T Tüting, CC Wilson, DM Martin, YL Kasamon, J Rowles, DI Ma, ...
The Journal of Immunology 160 (3), 1139-1147, 1998
2561998
Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive …
MJ Reinhardt, AY Joe, U Jaeger, A Huber, A Matthies, J Bucerius, ...
Journal of clinical oncology 24 (7), 1178-1187, 2006
2522006
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
M Hölzel, A Bovier, T Tüting
Nature Reviews Cancer 13 (5), 365, 2013
1992013
Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus
J Wenzel, E Wörenkämper, S Freutel, S Henze, O Haller, T Bieber, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005
1892005
Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing
N Gehrke, C Mertens, T Zillinger, J Wenzel, T Bald, S Zahn, T Tüting, ...
Immunity 39 (3), 482-495, 2013
1862013
Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO
G Wingender, N Garbi, B Schumak, F Jüngerkes, E Endl, D von Bubnoff, ...
European journal of immunology 36 (1), 12-20, 2006
1822006
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells
D Tormo, A Chęcińska, D Alonso-Curbelo, E Pérez-Guijarro, E Cañón, ...
Cancer cell 16 (2), 103-114, 2009
1632009
Gene-based strategies for the immunotherapy of cancer
T Tüting, WJ Storkus, MT Lotze
Journal of molecular medicine 75 (7), 478-491, 1997
1581997
Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope
A Gambotto, G Dworacki, V Cicinnati, T Kenniston, J Steitz, T Tüting, ...
Gene therapy 7 (23), 2036, 2000
1542000
Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells
R Backer, T Schwandt, M Greuter, M Oosting, F Jüngerkes, T Tüting, ...
Proceedings of the National Academy of Sciences 107 (1), 216-221, 2010
1532010
Immune cell–poor melanomas benefit from PD-1 blockade after targeted type I IFN activation
T Bald, J Landsberg, D Lopez-Ramos, M Renn, N Glodde, P Jansen, ...
Cancer discovery 4 (6), 674-687, 2014
1462014
Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity in vivo
T Tüting, AB Deleo, MT Lotze, WJ Storkus
European journal of immunology 27 (10), 2702-2707, 1997
1401997
The system can't perform the operation now. Try again later.
Articles 1–20